14-08-2024 04:53 PM | Source: Yes Securities Ltd
Neutral Vijaya Diagnostics Ltd For Target Rs. 800 By Yes Securities

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

https://t.me/InvestmentGuruIndiacom

Download Telegram App before Joining the Channel

Core growth unlikely to accelerate further

Result Synopsis

Vijaya management reiterated its capex plan involving addition of 9 hubs in rest of the fiscal spread across Pune, Kolkata and AP/Telangana. Volume growth across core markets has sprung a surprise translating into robust high teens footfall rise in standalone Vijaya. Albeit company has refrained from raising mid-teens growth expectation excluding PH Diagnostic. Bulk of the hub addition would occur in H2 which would drive growth in the next year. We raise footfall growth assumption by 200bps in FY25 while largely retaining FY26 volume growth of ~18%. However, increased volumes are partly offset by higher presumed operating expenses in lieu of capacity expansion leaving earnings estimates largely unchanged. In view of the run up since previous update, we downgrade to Neutral with unchanged target multiple and TP of Rs800, based on 40x FY26 EPS.

Result Highlights

Vijaya reported an inline quarter with revenue growth of 29% YoY which included exPH (acquired Pune based co) revenue growth of 19.5% YoY Ex-PH, volumes (patient footfalls) up 16.6% YoY while realization per patient up 5% YoY; total volumes up 22.5% YoY Margin at 39.2% came in line as no major incremental costs were loaded in Q1 Company opened a hub in Ongole, AP and achieved break even in Kolkata within 3 quarters PAT up 19% YoY, impacted by higher depreciation and lower other income YoY

 

Please refer disclaimer at https://yesinvest.in/privacy_policy_disclaimers
SEBI Registration number is INZ000185632.

To Read Complete Report & Disclaimer     Click Here

Views express by all participants are for information & academic purpose only. Kindly read disclaimer before referring below views. Click Here For Disclaimer